These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4159013)
1. Another chance for thalidomide. Floersheim GL Lancet; 1966 Jan; 1(7430):207. PubMed ID: 4159013 [No Abstract] [Full Text] [Related]
2. Effect of thalidomide on the immunological response in local lymph nodes after a skin homograft. Turk JL; Hellmann K; Duke DI Lancet; 1966 May; 1(7447):1134-6. PubMed ID: 4160863 [No Abstract] [Full Text] [Related]
3. Effect of thalidomide on survival of skin homografts in rabbits. Bore PJ; Scothorne RJ Lancet; 1966 Jun; 1(7449):1240-1. PubMed ID: 4161211 [No Abstract] [Full Text] [Related]
4. [Immunosuppression by cyclic imides in the rat]. Ellenrieder M; Frankus E; Krüpe W Klin Wochenschr; 1967 Nov; 45(22):1159-60. PubMed ID: 4874023 [No Abstract] [Full Text] [Related]
5. The effect of thalidomide on skin allografts in mice: survival of the grafts. Mouzas GL; Gershon RK Transplantation; 1968 May; 6(3):476-8. PubMed ID: 4871401 [No Abstract] [Full Text] [Related]
6. PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE. HELLMANN K; DUKE DI; TUCKER DF Br Med J; 1965 Sep; 2(5463):687-9. PubMed ID: 14337738 [No Abstract] [Full Text] [Related]
7. [Prolonged survival of homotransplantates of the skin using thalidomide]. Köhnlein HE; Lemperle G; Karges I Bruns Beitr Klin Chir (1971); 1969 Mar; 217(2):165-70. PubMed ID: 4392093 [No Abstract] [Full Text] [Related]
8. Failure of thalidomide to influence homograft immunity in chickens. Jaffe WP Vet Rec; 1966 Jun; 78(25):883-4. PubMed ID: 5336295 [No Abstract] [Full Text] [Related]
9. The immunosuppressive effects of adamantoyl cytarabine. II. Effects on skin allograft rejection by rats and mice. Gray GD; Mickelson MM Transplantation; 1970 Feb; 9(2):176-8. PubMed ID: 4905927 [No Abstract] [Full Text] [Related]
10. Immunosuppressive and specific antimitotic effects of ovalicin. Lazáry S; Stähelin H Experientia; 1968 Nov; 24(11):1171-3. PubMed ID: 4889119 [No Abstract] [Full Text] [Related]
11. [Behavior of cutaneous homografts in animals treated with anti-immunological substances]. Cagnoni G; Mazzoleni F; Paladini E; Visentini PA Arch Ital Sci Farmacol; 1965; 15(1):49-50. PubMed ID: 5331893 [No Abstract] [Full Text] [Related]
12. [Reserpine inhibition of the development of transplantation immunity]. Devoino LV; Korovina LS Patol Fiziol Eksp Ter; 1968; 12(3):33-5. PubMed ID: 4916668 [No Abstract] [Full Text] [Related]
13. Effect of methylhydrazine derivatives on the survival of second-set skin homografts. Floersheim GL Nature; 1966 Aug; 211(5049):638-9. PubMed ID: 5338821 [No Abstract] [Full Text] [Related]
14. Another chance for thalidomide? Lancet; 1965 Nov; 2(7421):1059. PubMed ID: 4159140 [No Abstract] [Full Text] [Related]
15. Correlation of tissue-typing tests in baboon renal allotransplants. Murphy GP; Brede HE; Weber HW; Retief FP; van Zyl JJ; van Zyl JA; de Klerk JN S Afr Med J; 1969 May; 43(22):689-94. PubMed ID: 4182220 [No Abstract] [Full Text] [Related]
16. Effect of graft removal and immunosuppression on antibody response to murine histocompatibility antigens. Sparks FC; Canty TG; Ting CC; Hammond WG; Heberman RB Rev Surg; 1970; 27(5):374. PubMed ID: 4922239 [No Abstract] [Full Text] [Related]
17. Successful treatment with thalidomide in a liver transplant recipient with giant esophageal ulcers. Atiq M; Neff GW; Argyropoulos C; Schroer M; Kemmer N; Weber F; Buell J Liver Transpl; 2006 Jun; 12(6):987-8. PubMed ID: 16721763 [No Abstract] [Full Text] [Related]